Browsing: Therapeutics

Up to $35 million from the Gates Foundation will support ProFound’s use of its platform, datasets, and algorithms to identify new drug targets and biomarkers for preeclampsia and eclampsia

Axsome Therapeutics (NASDAQ: AXSM), a biotech company, has performed fairly well this year. The company’s shares are up 16% versus the S&P 500’s 11%. Could the stock rise even higher? Wall Street certainly thinks so. Axsome Therapeutics’ average price target (according to Yahoo! Finance) of $285.42 implies about a 37% upside from its current level.…

Silence Therapeutics and AbCellera launched respective common share public offerings, and Beyang Therapeutics and Remepy closed $30+ million oversubscribed Series A rounds.

Second quarter 2026 net product revenue of $18.6 million; cash and cash equivalents of $219.1 million as of June 30, 2026

Beyang Therapeutics has raised nearly $30 million in an oversubscribed Series A financing round to advance its AI-powered drug discovery platform and clinical pipeline.

Welcome to our dedicated page for Attovia Therapeutics SEC filings (Ticker: ATTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Celldex Therapeutics, Inc. recently reported second-quarter 2026 results, with revenue falling to US$0.022 million and net loss widening to US$73.5 million, while loss per share from continuing operations increased to US$0.94.

Non-dilutive funding will support the commercialization, development, and expansion strategy for Sonire’s Ultrasound-Guided HIFU Platform